Cargando…

Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry

PURPOSE: Globally non-muscle invasive bladder cancer (NMIBC) is a high-incidence disease. There is a large heterogeneity within NMIBC regarding recurrence- and progression risks, and large-scale studies of treatment patterns and prognoses in an everyday setting could result in NMIBC-subgroup treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Blichert-Refsgaard, Linea, Nørgaard, Mette, Bengtsen, Maria Bisgaard, Jensen, Jørgen Bjerggaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648184/
https://www.ncbi.nlm.nih.gov/pubmed/36387926
http://dx.doi.org/10.2147/CLEP.S376566
_version_ 1784827522724134912
author Blichert-Refsgaard, Linea
Nørgaard, Mette
Bengtsen, Maria Bisgaard
Jensen, Jørgen Bjerggaard
author_facet Blichert-Refsgaard, Linea
Nørgaard, Mette
Bengtsen, Maria Bisgaard
Jensen, Jørgen Bjerggaard
author_sort Blichert-Refsgaard, Linea
collection PubMed
description PURPOSE: Globally non-muscle invasive bladder cancer (NMIBC) is a high-incidence disease. There is a large heterogeneity within NMIBC regarding recurrence- and progression risks, and large-scale studies of treatment patterns and prognoses in an everyday setting could result in NMIBC-subgroup treatment optimization, benefiting both patients and the economy. The Danish national registries provide such an opportunity if the registered procedure codes are valid. Therefore, the aim of the study was to validate the International Classification of Diseases, 10th Edition (ICD-10) codes of NMIBC treatment used in the Danish National Patient Registry (DNPR). PATIENTS AND METHODS: From the DNPR, we randomly selected 200 NMIBC treatment courses identified by the dates of the course and the codes of transurethral resection of the bladder ((TURB), n = 125), photodynamic diagnosis ((PDD), n = 25), bladder instillation with Bacillus Calmette vaccine ((BCG), n = 25), or bladder instillation with chemotherapy/Mitomycin C ((MMC), n = 25). We used medical record reviews as the reference standard and estimated positive predictive values (PPVs) of all procedure codes and negative predictive values (NPVs) of PDD- and the perioperative single-shot MMC codes. RESULTS: We identified the medical records in 150 (75%) of the 200 treatment courses (149 individual patients). The overall PPVs were TURB: 98.9% (95% confidence interval: 93.8; 100.0%), PDD: 95.8% (78.9; 99.9%), adjuvant BCG: 90.0% (68.3; 98.8%), perioperative single-shot MMC 1/5, and adjuvant MMC: 69.2% (38.6; 90.9%). The overall NPVs were PDD: 64.8% (54.4; 73.9%) and perioperative single-shot MMC: 97.7% (92.1; 99.4%). CONCLUSION: The ICD-10 NMIBC procedure codes recorded in the DNPR are generally valid with high PPVs. The NPV of the PPD code is acceptable. However, the code for perioperative single-shot MMC is uncertain with low PPV, but a high NPV.
format Online
Article
Text
id pubmed-9648184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96481842022-11-15 Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry Blichert-Refsgaard, Linea Nørgaard, Mette Bengtsen, Maria Bisgaard Jensen, Jørgen Bjerggaard Clin Epidemiol Original Research PURPOSE: Globally non-muscle invasive bladder cancer (NMIBC) is a high-incidence disease. There is a large heterogeneity within NMIBC regarding recurrence- and progression risks, and large-scale studies of treatment patterns and prognoses in an everyday setting could result in NMIBC-subgroup treatment optimization, benefiting both patients and the economy. The Danish national registries provide such an opportunity if the registered procedure codes are valid. Therefore, the aim of the study was to validate the International Classification of Diseases, 10th Edition (ICD-10) codes of NMIBC treatment used in the Danish National Patient Registry (DNPR). PATIENTS AND METHODS: From the DNPR, we randomly selected 200 NMIBC treatment courses identified by the dates of the course and the codes of transurethral resection of the bladder ((TURB), n = 125), photodynamic diagnosis ((PDD), n = 25), bladder instillation with Bacillus Calmette vaccine ((BCG), n = 25), or bladder instillation with chemotherapy/Mitomycin C ((MMC), n = 25). We used medical record reviews as the reference standard and estimated positive predictive values (PPVs) of all procedure codes and negative predictive values (NPVs) of PDD- and the perioperative single-shot MMC codes. RESULTS: We identified the medical records in 150 (75%) of the 200 treatment courses (149 individual patients). The overall PPVs were TURB: 98.9% (95% confidence interval: 93.8; 100.0%), PDD: 95.8% (78.9; 99.9%), adjuvant BCG: 90.0% (68.3; 98.8%), perioperative single-shot MMC 1/5, and adjuvant MMC: 69.2% (38.6; 90.9%). The overall NPVs were PDD: 64.8% (54.4; 73.9%) and perioperative single-shot MMC: 97.7% (92.1; 99.4%). CONCLUSION: The ICD-10 NMIBC procedure codes recorded in the DNPR are generally valid with high PPVs. The NPV of the PPD code is acceptable. However, the code for perioperative single-shot MMC is uncertain with low PPV, but a high NPV. Dove 2022-11-06 /pmc/articles/PMC9648184/ /pubmed/36387926 http://dx.doi.org/10.2147/CLEP.S376566 Text en © 2022 Blichert-Refsgaard et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Blichert-Refsgaard, Linea
Nørgaard, Mette
Bengtsen, Maria Bisgaard
Jensen, Jørgen Bjerggaard
Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title_full Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title_fullStr Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title_full_unstemmed Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title_short Positive Predictive Values of Procedure Codes on the Treatment of Non-Muscle Invasive Bladder Cancer in the Danish National Patient Registry
title_sort positive predictive values of procedure codes on the treatment of non-muscle invasive bladder cancer in the danish national patient registry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648184/
https://www.ncbi.nlm.nih.gov/pubmed/36387926
http://dx.doi.org/10.2147/CLEP.S376566
work_keys_str_mv AT blichertrefsgaardlinea positivepredictivevaluesofprocedurecodesonthetreatmentofnonmuscleinvasivebladdercancerinthedanishnationalpatientregistry
AT nørgaardmette positivepredictivevaluesofprocedurecodesonthetreatmentofnonmuscleinvasivebladdercancerinthedanishnationalpatientregistry
AT bengtsenmariabisgaard positivepredictivevaluesofprocedurecodesonthetreatmentofnonmuscleinvasivebladdercancerinthedanishnationalpatientregistry
AT jensenjørgenbjerggaard positivepredictivevaluesofprocedurecodesonthetreatmentofnonmuscleinvasivebladdercancerinthedanishnationalpatientregistry